iohexol has been researched along with Hepatitis B, Chronic in 3 studies
Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.
Hepatitis B, Chronic: INFLAMMATION of the LIVER in humans caused by HEPATITIS B VIRUS lasting six months or more. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Plasmas from chronic hepatitis B (CHB) patients, HBeAg positive or negative, genotype D or E, were fractionated on velocity and equilibrium gradients with or without detergent treatment." | 1.72 | Characterization of hepatitis B viral forms from patient plasma using velocity gradient: Evidence for an excess of capsids in fractions enriched in Dane particles. ( Besombes, J; Bomo, J; Genet, V; Gripon, P; Laperche, S; Pronier, C; Thibault, V, 2022) |
| "Common enhancement pattern of intrahepatic cholangiocarcinoma (ICC) on computed tomography (CT) is that of hypovascular enhancement; however, in some cases, tumor shows identical enhancement in the arterial phase to that in hepatocellular carcinoma." | 1.35 | Relationship between pattern of tumor enhancement and clinicopathologic characteristics in intrahepatic cholangiocarcinoma. ( Abo, T; Fukuoka, H; Hidaka, S; Murakami, G; Nagayasu, T; Nanashima, A; Oikawa, M; Sakamoto, I; Sawai, T; Sumida, Y; Takeshita, H, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Pronier, C | 3 |
| Bomo, J | 3 |
| Besombes, J | 3 |
| Genet, V | 3 |
| Laperche, S | 3 |
| Gripon, P | 3 |
| Thibault, V | 3 |
| Li, R | 1 |
| Cai, P | 1 |
| Ma, KS | 1 |
| Ding, SY | 1 |
| Guo, DY | 1 |
| Yan, XC | 1 |
| Nanashima, A | 1 |
| Sumida, Y | 1 |
| Abo, T | 1 |
| Oikawa, M | 1 |
| Murakami, G | 1 |
| Takeshita, H | 1 |
| Fukuoka, H | 1 |
| Hidaka, S | 1 |
| Nagayasu, T | 1 |
| Sakamoto, I | 1 |
| Sawai, T | 1 |
3 other studies available for iohexol and Hepatitis B, Chronic